Previous studies have confirmed the role of TNF-α in promoting the pathogenesis of SARS-CoV infection through its receptors and suggested that the inhibition of TNF-α signaling might be leveraged as a treatment strategy (McDermott et al., 2016). The gene discussed is TNF; the disease is severe acute respiratory syndrome.